NULL
Indiana

Lilly to Present Clinical Data for Verzenio® (abemaciclib) and Real-World Evidence across HR+, HER2- Metastatic Breast Cancer at 2018 SABCS

INDIANAPOLIS, Nov. 29, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the upcoming presentation of clinical data at the 2018 San Antonio Breast Cancer Symposium (SABCS) in San…
Continue Reading »